Skip to main content
. 2022 Jul 8:10.1111/ene.15477. Online ahead of print. doi: 10.1111/ene.15477

FIGURE 1.

FIGURE 1

Overall recovery and residual symptoms in multiple sclerosis (MS) patients after COVID‐19 compared to MS controls. M3, 3 months after COVID‐19 diagnosis; M6, 6 months after COVID‐19 diagnosis; M12, 12 months after COVID‐19 diagnosis. Probability values were calculated by Fisher exact test comparing frequency at M3/M6/M12 in the MS + COVID cohort to MS controls